ML-02 MULTIAGENT IMMUNOCHEMOTHERAPY, R-MPV-A, FOR PATIENTS WITH SECONDARY CENTRAL NERVOUS SYSTEM LYMPHOMA

Lignende værker

• ML-02 Chemotherapy for patients with relapsed or refractory primary CNS lymphoma
  af: Nagane, Motoo, et al.
  Udgivet: (2020)
• CTNI-65. COMBINED RITUXIMAB, METHOTREXATE, PROCARBAZINE, VINCRISTINE, AND CYTARABINE (R-MPV-A) TREATMENT FOR PATIENTS WITH RELAPSED PRIMARY CNS LYMPHOMA
  af: Nagane, Motoo, et al.
  Udgivet: (2020)
• ML-21 Tirabrutinib monotherapy for relapsed/refractory primary central nervous system lymphoma
  af: Kobayashi, Keiichi, et al.
  Udgivet: (2020)
• STMO-09 Recovery from speech deficit after injury to frontal aslant tract in glioma surgery
  af: Saito, Kuniaki, et al.
  Udgivet: (2020)
• ACTR-47. COMBINED TREATMENT WITH HYPOFRACTIONATED RADIOTHERAPY AND TEMOZOLOMIDE BENEFITS OVER SINGLE TREATMENT IN ELDERLY PATIENTS WITH METHYLATED BUT NOT UNMETHYLATED MGMT GLIOBLASTOMA
  af: Nagane, Motoo, et al.
  Udgivet: (2017)